Surgery Partners, Inc. (NASDAQ:SGRY) Receives Average Rating of “Moderate Buy” from Brokerages

Surgery Partners, Inc. (NASDAQ:SGRY) has been given a consensus rating of “Moderate Buy” by the nine research firms that are presently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $33.00.

Several equities research analysts have weighed in on SGRY shares. Barclays cut their price target on Surgery Partners from $25.00 to $24.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 27th. Bank of America assumed coverage on shares of Surgery Partners in a research report on Monday, July 28th. They set a “buy” rating and a $28.00 price target on the stock.

Insider Buying and Selling

In other Surgery Partners news, Director Teresa Deluca sold 20,018 shares of the stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $22.74, for a total value of $455,209.32. Following the completion of the transaction, the director directly owned 45,173 shares of the company’s stock, valued at approximately $1,027,234.02. This trade represents a 30.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 2.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Surgery Partners

A number of hedge funds have recently made changes to their positions in the stock. GAMMA Investing LLC increased its position in shares of Surgery Partners by 7,902.7% in the 1st quarter. GAMMA Investing LLC now owns 8,883 shares of the company’s stock worth $211,000 after purchasing an additional 8,772 shares during the last quarter. Northern Trust Corp increased its position in shares of Surgery Partners by 2.1% in the 4th quarter. Northern Trust Corp now owns 761,790 shares of the company’s stock worth $16,127,000 after purchasing an additional 15,657 shares during the last quarter. Allianz Asset Management GmbH bought a new stake in shares of Surgery Partners during the 1st quarter valued at about $420,000. Bank of New York Mellon Corp grew its position in shares of Surgery Partners by 0.3% during the 1st quarter. Bank of New York Mellon Corp now owns 341,702 shares of the company’s stock valued at $8,115,000 after buying an additional 926 shares during the last quarter. Finally, Principal Financial Group Inc. grew its position in shares of Surgery Partners by 9.5% during the 1st quarter. Principal Financial Group Inc. now owns 54,266 shares of the company’s stock valued at $1,289,000 after buying an additional 4,717 shares during the last quarter.

Surgery Partners Price Performance

Shares of NASDAQ SGRY opened at $23.84 on Thursday. The company has a quick ratio of 1.78, a current ratio of 1.93 and a debt-to-equity ratio of 1.10. The firm has a market capitalization of $3.06 billion, a P/E ratio of -16.67 and a beta of 1.82. The stock’s 50-day simple moving average is $22.12 and its two-hundred day simple moving average is $22.94. Surgery Partners has a twelve month low of $18.87 and a twelve month high of $33.97.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The company had revenue of $826.20 million during the quarter, compared to analyst estimates of $816.96 million. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The firm’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter last year, the company earned $0.21 EPS. As a group, equities analysts anticipate that Surgery Partners will post 0.67 EPS for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.